The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

QY Research Reports

Synopsis Ranibizumab is a medication used to manage and treat neovascular age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, myopic choroidal neovascularization, and diabetic retinopathy. Glo.....

No Of Pages : 74
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

Synopsis Pegfilgrastim, sold under the brand name Neulasta among others, is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (GCSF) analog filgrastim.It serves to stimulate the production .....

No Of Pages : 91
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

Synopsis Infliximab is a monoclonal anti tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis. Avsola, Flixabi, Inf.....

No Of Pages : 69
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

Synopsis Infliximab is a monoclonal anti tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis. Avsola, Flixabi, Inf.....

No Of Pages : 66
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

Synopsis RITUXAN® (rituximab) is a prescription medicine used to treat: Adults with Non-Hodgkin's Lymphoma (NHL): alone or with other chemotherapy medicines. Children 6 months of age and older with mature B-cell Non-Hodgkin's L.....

No Of Pages : 73
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

Synopsis RITUXAN® (rituximab) is a prescription medicine used to treat: Adults with Non-Hodgkin's Lymphoma (NHL): alone or with other chemotherapy medicines. Children 6 months of age and older with mature B-cell Non-Hodgkin's L.....

No Of Pages : 68
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

Synopsis An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be di.....

No Of Pages : 92
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

Synopsis THYROGEN (thyrotropin alfa for injection) contains recombinant human thyroid stimulating hormone (TSH). Thyrotropin alfa is synthesized in a genetically modified Chinese hamster ovary cell line. Global Thyrogen and Biosimilar market is p.....

No Of Pages : 66
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

Synopsis Diagnosis is an integral part of disease prevention and management as a minor outbreak of the disease can spread quickly and pose a threat to the entire population in the vicinity. Disease diagnosis of an animal forms the connecting link between.....

No Of Pages : 91
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

Synopsis Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. Global Trastuzumab Monoclonal Antibody market is projected to reach US$ 6303.7 million in 2029, incre.....

No Of Pages : 86
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00